Standard BioTools Inc. (LAB) — 分析師展望 / 分析師共識目標價為. 基於 10 位分析師評級, 共識為 看漲 — 6 買入, 4 持有.
分析師共識目標價為 $3.25, 上漲空間為 232.5% 相對於當前價格 $0.98.
分析師預估 每股收益(EPS)為 $-0.36 和 營收為 $0.17B (下一財年).
每股收益(EPS)歷史表現: 2024: 實際 $-0.52 vs 預期 $-0.36 (不及預期 -45.8%). 2025: 實際 $-0.20 vs 預期 $-0.21 (超預期 +3.5%). 分析師準確度: 83%.
LAB 股票 — 12個月價格預測
$3.25
▲ +232.48% 上漲空間
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for Standard BioTools Inc., the price target is $3.25.
平均目標價相對最新價格 $0.98 變動 +232.48%。
LAB 分析師評級
Buy
基於過去3個月內 10 位分析師對 Standard BioTools Inc. 的評級
EPS 預測 — LAB
83%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.52
vs Est –$0.36
▼ 31.4% off
2025
Actual –$0.20
vs Est –$0.21
▲ 3.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
營收預測 — LAB
96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.174B
vs Est $0.171B
▲ 1.9% off
2025
Actual $0.085B
vs Est $0.080B
▲ 5.9% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
